PyInvesting

Market research

4554.TSE Fuji Pharma Co., Ltd

TSE JPY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
46B
P/E ratio
14.84
Analyst target
2950
Dividend yield
2.6%
Beta
0.33

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Fuji Pharma Co., Ltd is currently in a long term downtrend where the price is trading 8.9% below its 200 day moving average.

From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.

Fuji Pharma Co., Ltd's total revenue rose by 3.6% to $9B since the same quarter in the previous year.

Its net income has increased by 78.3% to $1B since the same quarter in the previous year.

Based on the above factors, Fuji Pharma Co., Ltd gets an overall score of 3/5.